AI assistant
Axogen, Inc. — Director's Dealing 2015
Dec 30, 2015
32414_dirs_2015-12-30_43159236-193e-42c5-8743-518bccadf141.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2015-12-28
Reporting Person: Grooms Jamie Mark (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-12-28 | Stock Option (right to purchase) | $5.09 | A | 15000 | Acquired | 2015-12-29 | Common Stock (15000) | Direct |
Footnotes
F1: The option vests in four equal quarterly installments beginning on March 31, 2016, becoming fully vested on December 31, 2016.
F2: The option is not exercisable until such time as the number of shares reserved for issuance under the AxoGen, Inc. 2010 Stock Incentive Plan, as amended and restated, have been increased by an affirmative vote of the shareholders of AxoGen, Inc. in an amount that exceeds the shares of Common Stock issuable upon exercise of the option and all other options containing this provision granted prior to such shareholder vote.